Combined Breast Cancer Risk Study

计划入组 553 人 · 首次发布于 2017 年 3 月 1 日

MIRAI-MRI: Comparing Screening MRI for Patients at High Risk for Breast Cancer Identified by Mirai and Tyrer-Cuzick

计划入组 145 人 · 首次发布于 2023 年 8 月 1 日

Breast cancer prevention in women at increased risk using low dose tamoxifen and/or diet and life style changes: a randomized 4 arms clinical study

计划入组 110 人 · 首次发布于 2023 年 7 月 17 日

scFv-h3D6

Bapineuzumab

EBV Nanoparticle Vaccine (Modex)

Clarion Model Clinic Pty Ltd

Australia

Shanghai Kaibao Pharmaceutical Co.,Ltd.

China

Stereotaxis

United States

Myriad Genetics' RiskScore Study Recognized as a Top Advance in Genomic Medicine

Myriad Genetics' RiskScore Study Shows Improved Breast Cancer Screening Personalization

Clairity, Myriad Genetics, and MagView Launch First Integrated AI-Genetic Risk Platform for Breast Cancer Screening